Comment on ‘Spongiotic psoriasiform dermatitis with dual features of eczema and psoriasis: Janus kinase inhibition as a potential therapeutic option’: a new therapy
We read with interest the article by Cheng et al., who evaluated patients with spongiotic psoriasiform dermatitis using histopathological and multiplex immunofluorescence analyses. We add some new perspectives and provide a few suggestions.
Authors
- Bao Li (ORCID: https://orcid.org/0000-0003-1154-6423)
- Chao Gao (ORCID: https://orcid.org/0000-0003-1552-0343)
Institutions
- Jinhua Academy of Agricultural Sciences (CN)
- Guang Fu Hospital (CN)
- Zhoushan Hospital (CN)
- Jinhua Central Hospital (CN)
Publication Details
- Journal
- Clinical and Experimental Dermatology
- Published
- 2025-12-14
- DOI
- https://doi.org/10.1093/ced/llaf544
- Primary Topic
- Psoriasis: Treatment and Pathogenesis
- Type
- article
- Field-Weighted Citation Impact
- 0.00